Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM

Smith Hunter C exercised options for 3,000 Rhythm Pharmaceuticals, Inc. shares (Form 4)

Traded May 18, 2026 · Filed May 20, 2026

On May 18, 2026, Smith Hunter C (Chief Financial Officer) exercised options for 3,000 Rhythm Pharmaceuticals, Inc. shares at US$17.87 for US$53,610, leaving 119,611 shares. Filed May 20, 2026 (Form 4).

Options exercised
3,000 shares
Price
US$17.87
Value
US$53,610
Holding after
119,611 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 18, 2026Common StockOption exercise3,000US$17.87119,611Direct

Source

View original at SEC

Related